British American Tobacco (BATSN) AI Stock Analysis
British American Tobacco
(BMV:BATSN)
No summary available
British American Tobacco (BATSN) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- MXN 98.70B
- Dividend Yield
- 6.76%
- Average Volume (3M)
- 860
- Price to Earnings (P/E)
- 15.7
- Beta (1Y)
- 0.19
- Revenue Growth
- -4.69%
- EPS Growth
- 93.51%
- Country
- Mexico
- Employees
- 47,797
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Tobacco
British American Tobacco Business Overview & Revenue Model
Company Description
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa. The company offers vapour products; heated...
British American Tobacco Earnings Call Summary
The call presented clear positive momentum across New Categories (notably Modern Oral) and a strong U.S. multi-category performance, with solid margin expansion, EPS growth (adjusted EPS +7.9%), and progress on cost transformation and cash returns. Significant regional weaknesses (notably APMEA), declines in Heated Products and Vapour in some markets, regulatory and illicit challenges, and sizeable one-off charges temper the outlook. On balance, achievements (accelerating New Category profitability, upgraded EPS guidance, margin and cash strength, Fit2Win savings visibility) outweigh the regional and category headwinds, supporting a constructive outlook while acknowledging near-term moderation and investment-driven costs.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Guidance summary: management expects adjusted profit from operations to accelerate in H2 (profit second‑half weighted) driven by improvements in AME and APMEA and the phasing benefit of Fit2Win, with New Category revenue growth targeted at mid‑teens in H2 led by Velo and Vuse; full‑year revenue and operating profit are expected at the lower end of the company’s algorithm/range, absorbing around a 1% transactional FX headwind, and full‑year EPS growth is now guided toward the middle of the 5–8% range. Financial assumptions include net finance cost of ~GBP 1.65bn and an underlying tax rate of 24–25%; Fit2Win savings are expected to reach GBP 700m annualized by 2028 (GBP 500m by 2027) with total one‑off costs of ~GBP 950m (GBP 840m adjusting) mainly in 2026–27. Capital allocation and cash priorities remain intact: targeting 2–2.5x leverage by year‑end, a GBP 1.3bn share buyback in 2026 alongside a progressive dividend, and a commitment to deliver more than GBP 50bn of free cash flow by 2030.
British American Tobacco Risk Analysis
British American Tobacco disclosed 1 risk factors in its most recent earnings report. British American Tobacco reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
1 New RiskBritish American Tobacco Peers Comparison
Overall Rating
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MX:BATSN | British American Tobacco (UK) | 964.31 | -62.53 | -6.09% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.